Market Overview:
The global prostate cancer treatment device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of prostate cancer, technological advancements in prostate cancer treatment devices, and increasing demand for minimally invasive treatments. Based on type, the radiation therapy segment is expected to account for the largest share of the global prostate cancer treatment device market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to increasing use of radiation therapy as a primary or adjuvant treatment for prostate cancer patients. Based on application, hospitals are expected to account for the largest share of the global prostate cancer treatment device market in 2018.
Product Definition:
A prostate cancer treatment device is a medical device used to treat prostate cancer. The most common type of prostate cancer treatment device is the radiation therapy machine, which uses high-energy X-rays to kill tumor cells. Other types of prostate cancer treatment devices include brachytherapy (radioactive seeds inserted into the tumor), cryotherapy (freezing the tumor), and surgery.
Radiation:
Radiation is the energy released by the radioactive element. The most common type of radiation used in medical procedures is ionizing radiation which consists of alpha, beta, and gamma rays. Ions are particles that have lost one or more electrons and are electrically charged. Ions can be naturally occurring or man-made (artificial) ions.
High-Intensity Focused Ultrasound (HIFU):
High-intensity focused ultrasound (HIFU) is a new noninvasive treatment for prostate cancer that uses high-frequency sound waves to destroy tissues. The FDA has approved the use of HIFU devices for the treatment of localized prostate cancer, which means that manufacturers have approval to sell their products as medical devices. However, there are no guarantees about its effectiveness or safety in treating prostate cancer.
Application Insights:
The others segment held the largest share of over 50.0% in 2017 and is expected to witness significant growth during the forecast period owing to an increase in the adoption of these devices outside hospitals as well as specialty centers. The radiation oncology segment is expected to be one of the major revenue contributors during the forecast period due to a rise in prostate cancer cases that require treatment with radiation or hormonal therapy.
Hospitals were estimated as the largest application segment for prostate cancer treatment devices, accounting for around 60% share of total revenue in 2017. This can be attributed mainly due to factors such as availability of highly skilled staff, advanced healthcare facilities along with a large number prostate cancer patients requiring long-term care at any given time; thus resulting in high demand for medical equipment and supplies at hospitals across various regions globally.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of prostate cancer and high adoption of technologically advanced products. Moreover, government initiatives for raising awareness about early diagnosis are expected to fuel growth during the forecast period. For instance, The Prostate Cancer Foundation (PCF) was established by PC doctors and raises funds for research & education programs that focus on prostate cancer detection & prevention.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to rising healthcare expenditure by governments as well as private players coupled with increasing patient pool due to aging demographics in countries like Japan and China. In addition, economic development has led towards improvement in healthcare infrastructure which is further anticipated boost regional growth during the forecast period (2018-2030). However, low treatment rates along with lack of proper reimbursement policies may hinder market growth over this decade.
Growth Factors:
- Increasing incidence of prostate cancer
- Growing awareness about prostate cancer and its treatment options
- Rising demand for minimally invasive procedures for prostate cancer treatment
- Technological advancements in prostate cancer treatment devices
- Growing number of clinical studies on new prostate cancer treatment devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Prostate Cancer Treatment Device Market Research Report
By Type
Radiation, High-Intensity Focused Ultrasound (HIFU), Cryotherapy, Others
By Application
Hospitals, Specialty Centers, Others
By Companies
SonaCare Medical, EDAP TMS, Profound Medical Corporation, Eckert and Ziegler, HealthTronics, Boston Scientific, Elekta AB, Accuray Incorporated, Varian Medical Systems, Becton, Dickinson and Company, Intuitive Surgical, ViewRay, Provision Healthcare, Isoray, Theragenics Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Prostate Cancer Treatment Device Market Report Segments:
The global Prostate Cancer Treatment Device market is segmented on the basis of:
Types
Radiation, High-Intensity Focused Ultrasound (HIFU), Cryotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SonaCare Medical
- EDAP TMS
- Profound Medical Corporation
- Eckert and Ziegler
- HealthTronics
- Boston Scientific
- Elekta AB
- Accuray Incorporated
- Varian Medical Systems
- Becton, Dickinson and Company
- Intuitive Surgical
- ViewRay
- Provision Healthcare
- Isoray
- Theragenics Corporation
Highlights of The Prostate Cancer Treatment Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiation
- High-Intensity Focused Ultrasound (HIFU)
- Cryotherapy
- Others
- By Application:
- Hospitals
- Specialty Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prostate Cancer Treatment Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prostate cancer treatment device is a medical device that is used to treat prostate cancer. Treatment devices can include, but are not limited to, radiation therapy machines, chemotherapy drugs, and surgery.
Some of the key players operating in the prostate cancer treatment device market are SonaCare Medical, EDAP TMS, Profound Medical Corporation, Eckert and Ziegler, HealthTronics, Boston Scientific, Elekta AB, Accuray Incorporated, Varian Medical Systems, Becton, Dickinson and Company, Intuitive Surgical, ViewRay, Provision Healthcare, Isoray, Theragenics Corporation.
The prostate cancer treatment device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prostate Cancer Treatment Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prostate Cancer Treatment Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prostate Cancer Treatment Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prostate Cancer Treatment Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prostate Cancer Treatment Device Market Size & Forecast, 2018-2028
4.5.1 Prostate Cancer Treatment Device Market Size and Y-o-Y Growth
4.5.2 Prostate Cancer Treatment Device Market Absolute $ Opportunity
Chapter 5 Global Prostate Cancer Treatment Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prostate Cancer Treatment Device Market Size Forecast by Type
5.2.1 Radiation
5.2.2 High-Intensity Focused Ultrasound (HIFU)
5.2.3 Cryotherapy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prostate Cancer Treatment Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prostate Cancer Treatment Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prostate Cancer Treatment Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prostate Cancer Treatment Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prostate Cancer Treatment Device Analysis and Forecast
9.1 Introduction
9.2 North America Prostate Cancer Treatment Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prostate Cancer Treatment Device Market Size Forecast by Type
9.6.1 Radiation
9.6.2 High-Intensity Focused Ultrasound (HIFU)
9.6.3 Cryotherapy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prostate Cancer Treatment Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prostate Cancer Treatment Device Analysis and Forecast
10.1 Introduction
10.2 Europe Prostate Cancer Treatment Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prostate Cancer Treatment Device Market Size Forecast by Type
10.6.1 Radiation
10.6.2 High-Intensity Focused Ultrasound (HIFU)
10.6.3 Cryotherapy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prostate Cancer Treatment Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prostate Cancer Treatment Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prostate Cancer Treatment Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prostate Cancer Treatment Device Market Size Forecast by Type
11.6.1 Radiation
11.6.2 High-Intensity Focused Ultrasound (HIFU)
11.6.3 Cryotherapy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prostate Cancer Treatment Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prostate Cancer Treatment Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Prostate Cancer Treatment Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prostate Cancer Treatment Device Market Size Forecast by Type
12.6.1 Radiation
12.6.2 High-Intensity Focused Ultrasound (HIFU)
12.6.3 Cryotherapy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prostate Cancer Treatment Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prostate Cancer Treatment Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prostate Cancer Treatment Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prostate Cancer Treatment Device Market Size Forecast by Type
13.6.1 Radiation
13.6.2 High-Intensity Focused Ultrasound (HIFU)
13.6.3 Cryotherapy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prostate Cancer Treatment Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prostate Cancer Treatment Device Market: Competitive Dashboard
14.2 Global Prostate Cancer Treatment Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SonaCare Medical
14.3.2 EDAP TMS
14.3.3 Profound Medical Corporation
14.3.4 Eckert and Ziegler
14.3.5 HealthTronics
14.3.6 Boston Scientific
14.3.7 Elekta AB
14.3.8 Accuray Incorporated
14.3.9 Varian Medical Systems
14.3.10 Becton, Dickinson and Company
14.3.11 Intuitive Surgical
14.3.12 ViewRay
14.3.13 Provision Healthcare
14.3.14 Isoray
14.3.15 Theragenics Corporation
